Infusion Site Failure Detection Using Glucose and Insulin Data

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Infusion sites in insulin delivery systems can become less effective over time, leading to issues such as leakage, hyperglycemia, and ketones in the blood, which are not easily detected and can prolong hyperglycemic events if not addressed promptly.

Innovation Solution

A system utilizing a model-based approach with a trained machine learning model and a rule-based approach to analyze physiological glucose and insulin delivery data to predict infusion site failure, providing real-time alerts and recommendations for site replacement.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If infusion sets are used for extended periods to reduce replacement frequency, then patient convenience and system cost are improved, but the reliability of insulin delivery deteriorates as sites become less effective over time

Engineering Contradiction:
Improveinfusion set usage durationVSAvoidinsulin delivery effectiveness
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The system performs preliminary detection of infusion site failure by continuously monitoring glucose data and insulin delivery patterns, identifying signs of site deterioration before complete failure occurs. This allows proactive site replacement while the infusion set is still functional, resolving the contradiction by enabling extended usage duration while maintaining reliability through early failure detection.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If infusion site failure is detected earlier using advanced monitoring, then reliability is improved, but device complexity increases due to additional sensors and processing requirements

Engineering Contradiction:
Improveinfusion site failure detection accuracyVSAvoidmonitoring system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system uses the existing glucose sensor and insulin pump data to detect infusion site failure, rather than adding separate detection sensors. The glucose data and insulin delivery records already collected for therapy management are repurposed for failure detection, eliminating the need for additional hardware and keeping device complexity low while maintaining high reliability.

Inventive Principle:
Principle #25Self-service

3Measurement precision

If continuous monitoring of glucose and insulin data is performed to detect site failure, then detection accuracy is improved, but energy consumption increases

Engineering Contradiction:
Improveinfusion site status detection accuracyVSAvoiddata processing energy consumption
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

The system performs partial monitoring by selectively analyzing glucose and insulin data only when infusion site failure is suspected or at scheduled intervals, rather than continuously processing all data. This reduces energy consumption while maintaining sufficient detection accuracy by focusing computational resources on critical detection moments rather than constant analysis.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS20260057994A1Infusion site failure detection
Publication Date: 2026.02.26 ELI LILLY & CO
  • US20260057994A1 patent drawing
  • US20260057994A1 patent drawing
  • US20260057994A1 patent drawing

AI summary

Systems, methods, and devices are provided for predicting a status of an infusion site. Approaches include applying a regression model to physiological glucose data and insulin delivery data to generate predictive data, operating a trained machine learning model to process the predictive data to generate an output, and determining that the infusion site has failed or is likely to have failed based on the output.